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Leprosy in children younger than 15 years old is 
correlated with recent disease and active foci of trans-
mission in the community, reflecting the efficiency of 
local control programmes. In the state of Pará (PA), in 
the Brazilian Amazon Region, leprosy is hyperendemic 
in this age group. This state had an annual case detec-
tion rate of 20.4/100,000 people in 2008, which is much 
higher than the Brazilian average of 5.8/100,000 people 
(MS/SVS 2009), indicating that Mycobacterium leprae 
is circulating amongst the children in PA. Furthermore, 
in highly endemic areas, the prevalence of previously un-
diagnosed leprosy in the general population is six times 
higher than the registered prevalence (Moet et al. 2008).
In Brazil, the primary health service is responsible 
for diagnosing leprosy, finding active cases of leprosy, 
tracing the patients’ contacts, treating leprosy and pre-
venting disability in the people affected by leprosy, 
but only 42% of the total population of PA is covered 
by these services (Department of Health Care/Depart-
ment of Primary Care 2012 - dab.saude.gov.br/histori-
co_cobertura_sf.php). This scenario suggests that there 
may be many patients with undiagnosed leprosy in PA 
who are perpetuating the transmission of the bacillus. 
Additionally, because of the long incubation period of 
M. leprae, more leprosy patients (LPs) are expected to 
emerge in the coming decades. 
The diagnosis of leprosy is based primarily on a clini-
cal examination and there is no laboratory test that detects 
all forms of leprosy. Because of the isolation and char-
acterisation of phenolic glycolipid-I (PGL-I) (Hunter & 
Brennan 1981), a species-specific antigen from the M. 
leprae cell wall, various studies have demonstrated that 
serology could potentially be used to detect antibodies 
against PGL-I to classify patients for treatment purposes, 
monitor cases, identify the risk of relapse and identify the 
household contacts (HHCs) of LPs who are at a higher risk 
of contracting the disease than the general public (Moura 
et al. 2008). A positive test for anti-PGL-I is associated 
with an 8.6-fold higher risk of leprosy in HHCs and a 4.4-
fold higher risk in non-contacts (Brasil et al. 2003). 
Some studies have shown that subclinical infections 
with M. leprae are much more common than overt disease 
in endemic communities (Godal & Negassi 1973, Abe et 
al. 1990, Barreto et al. 2011) and that anti-PGL-I sero-
positivity is a marker of subclinical infection (Baumgart 
et al. 1993, Lobato et al. 2011). Van Beers et al. (1999) in-
dicated that the seropositivity rates amongst school chil-
dren (SC) may reflect leprosy incidence. Seroprevalence 
may be an appropriate indicator of the magnitude of the 
burden of leprosy in a selected area. 
Therefore, screening to determine the seroepidemiol-
ogy of anti-PGL-I in hyperendemic areas may be useful 
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Leprosy in children is correlated with community-level factors, including the recent presence of disease and ac-
tive foci of transmission in the community. We performed clinical and serological examinations of 1,592 randomly 
selected school children (SC) in a cross-sectional study of eight hyperendemic municipalities in the Brazilian Ama-
zon Region. Sixty-three (4%) SC, with a mean age of 13.3 years (standard deviation = 2.6), were diagnosed with lep-
rosy and 777 (48.8%) were seropositive for anti-phenolic glycolipid-I (PGL-I). Additionally, we evaluated 256 house- 
hold contacts (HHCs) of the students diagnosed with leprosy; 24 (9.4%) HHC were also diagnosed with leprosy and 
107 (41.8%) were seropositive. The seroprevalence of anti-PGL-I was significantly higher amongst girls, students 
from urban areas and students from public schools (p < 0.0001). Forty-five (71.4%) new cases detected amongst SC 
were classified as paucibacillary and 59 (93.6%) patients did not demonstrate any degree of physical disability at 
diagnosis. The results of this study suggest that there is a high rate of undiagnosed leprosy and subclinical infection 
amongst children in the Amazon Region. The advantages of school surveys in hyperendemic areas include identify-
ing leprosy patients at an early stage when they show no physical disabilities, preventing the spread of the infection 
in the community and breaking the chain of transmission. 
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in identifying subclinical infections amongst children in 
the general population. In addition, combined with clini-
cal examinations of randomly selected subjects, screen-
ing tests could help to estimate the true burden of the 
disease in a specific region. Thus, the objectives of this 
study were to determine the prevalence of subclinical 
infection (defined in this study as seropositivity for anti-
PGL-I IgM with no clinical signs or symptoms of lepro-
sy) and the prevalence of undiagnosed leprosy amongst 
SC from selected municipalities in PA.
SuBJeCtS, MAteRiALS And MetHodS
Study design, setting and population - We conducted 
a cross-sectional study in eight inner counties of PA, 
from 2009-2011. Table I shows the demographics and 
epidemiological characteristics of the selected munici-
palities and Fig. 1 illustrates their geographic locations. 
The PA counties were selected based on their geographic 
position to sample all of the regions of the state and to 
accommodate PA’s leprosy clusters 1 and 7, as identified 
by Penna et al. (2009).
Participants - A team of health care professionals with 
experience in leprosy, including dermatologists, nurses, 
physical therapists, researchers and a lab technician, trav-
elled to the municipalities and visited 37 randomly select-
ed public elementary and high schools. At each school, 
two-four classes (approximately 60 subjects) of students 
aged six-20 years were randomly selected. The teachers, 
selected students and their parents received general in-
formation about leprosy and the main objectives of the 
study. The students who agreed to participate provided 
their written consent; for the participants younger than 
18 years old, consent was obtained from the parents or 
another responsible adult within the family.
Next, the students were clinically evaluated by a 
dermatologist and a sample of peripheral blood was col-
lected from each subject to determine the prevalence of 
IgM antibodies against PGL-I. When a new leprosy case 
was detected amongst the students, we travelled to their 
homes to evaluate the HHCs of the students diagnosed 
with leprosy. There were no restrictions on study partici-
pation based on gender, skin colour or comorbidities. To 
compare the anti-PGL-I titration levels of students with 
well-established leprosy cases, we included 51 patients 
[41 multibacillary (MB) and 10 paucibacillary (PB)] di-
agnosed at the Dr Marcello Candia Reference Unit in 
Sanitary Dermatology (UREMC) in PA. Additionally, 
45 healthy students, aged seven-17 years, from private 
schools in Belém, PA’s capital, were sampled and evalu-
ated for anti-PGL-I titration levels.
Diagnostic procedures - The diagnosis of a new lep-
rosy case was based on the identification of a skin lesion 
with sensory loss. A case was classified as indetermi-
nate leprosy if there was a hypopigmented macule, but 
no detection of nerve involvement, or the case was clas-
sified as one of the clinical forms defined by the Ridley 
and Jopling (1966) classification system [tuberculoid-tu-
berculoid (TT), borderline tuberculoid (BT), borderline-
borderline, borderline lepromatous or lepromatous-lep-
romatous (LL)]. Cases of indeterminate and TT leprosy 
were classified as PB cases, while the other forms were 
classified as MB cases. Primary neural leprosy was di-
agnosed if nerve enlargement was detected, but no skin 
signs were present. When only one nerve was affected, 
the case was classified as PB; two or more enlarged 
nerves defined the case as MB.
Laboratory procedures - Seropositivity was deter-
mined with an enzyme-linked immunosorbent assay 
TABLE I
Characteristics of the selected municipalities
Municipality
Population
(2010)a
New cases detected 
(2006-2010)b
(n)
Annual new case 
detection rate per  
100,000 people 
(2009)b
Children among new 
cases of leprosy   
(2006-2010)b
 n (%) Endemicity levelc
Altamira 99,075 611 108.3 56 (9.2) Hyperendemic
Breves 92,860 233 42.0 34 (14.6) Hyperendemic
Castanhal 173,149 380 48.2 35 (9.2) Hyperendemic
Marituba 108,246 424 50.4 65 (15.3) Hyperendemic
Oriximiná 62,794 68 18.7 5 (7.3) Highly endemic
Paragominas 97,819 720 130.4 80 (11.1) Hyperendemic
Parauapebas 153,908 1,397 142.0 143 (10.2) Hyperendemic
Redenção 75,556 584 186.4 72 (12.3) Hyperendemic
Total 863,407 4,491 55.7d 490 (10.9) -
a: source: Brazilian Institute for Geography and Statistics (ibge.gov.br/estadosat/); b: calculated from The National Notifiable 
Diseases 2012 (portal.saude.gov.br/portal/saude/profissional/visualizar_texto.cfm?idtxt=31200); c: according to the parameters 
designated by the Brazilian Ministry of Health; d: average detection rate of the state of Pará (The National Notifiable Diseases 
2012 - portal.saude.gov.br/portal/saude/profissional/visualizar_texto.cfm?idtxt=31200).
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(ELISA) using native PGL-I, which was generously pro-
vided by Dr John Spencer of Colorado State University 
(USA). The cut-off for positive results was arbitrarily 
established at an optical density (OD) of 0.295, based on 
the average plus three times the standard deviation of 
the test results from 14 healthy subjects from the same 
hyperendemic area (endemic control). A detailed de-
scription of the laboratory procedures was previously 
reported (Barreto et al. 2011). 
Data analysis - Descriptive statistics were calculated 
and various statistical inference procedures were per-
formed with BioEstat 5.0 software (Institute for Sustain-
able Development Mamirauá, Tefé, Amazonas, Brazil). 
Statistical significance was assessed using a signifi-
cance level of 0.05 (two-tailed). The Student’s t-test or 
the Mann-Whitney U test was used to assess the quanti-
tative data from independent samples. A chi-square test 
or Fisher’s exact test was used to compare proportions 
between different groups when appropriate and Pear-
son’s coefficient was used to detect correlations between 
anti-PGL-I titres and the variables of interest. 
Ethics - This study conforms to the Declaration of 
Helsinki and was approved by the Institute of Health 
Sciences Research Ethical Committee at the Federal 
University of Pará (protocol 197/07 CEP-ICS/UFPA). 
ReSuLtS
A total of 1,592 students were examined (966 girls 
and 626 boys); the mean age was 12.3 [standard devia-
tion (SD) = 3.2) years. Sixty-three (4%) of these students 
were clinically diagnosed with leprosy and 777 (48.8%) 
tested positive for anti-PGL-I IgM. We also examined 
256 HHCs of the students diagnosed with leprosy at 
their homes (142 females and 114 males); the mean age 
was 25.7 (SD = 17.8) years. Twenty-four (9.4%) of the 
HHCs were also diagnosed with leprosy (Table II) and 
107 (41.8%) tested positive for anti-PGL-I IgM. Table II 
shows the seroprevalence and the number of new cases 
detected amongst the students and HHCs in each mu-
nicipality. Amongst the new cases detected, 51 (58.6%) 
were children younger than 15 years old. The distribu-
tion of cases by gender, age group, clinical classification, 
degree of physical disability, anti-PGL-I seropositivity 
and the presence of a BCG scar is shown in Table III. 
The levels of anti-PGL-I were similar in the MB pa-
tients (median OD = 0.369; IQR = 0.409) and the PB pa-
tients [median OD = 0.394; interquartile range (IQR) = 
0.445] diagnosed during the active survey of the students 
and their HHCs (p = 0.752) and the proportions of serop- 
ositivity were also similar (MB = 60.6%, PB = 66.7%; 
Fig. 1A, B: sample pictures of team work on the school and on the 
field; C: one of the children diagnosed with borderline lepromatous 
leprosy with her father, detected after our visit to her house.
Fig. 2: geographic locations of the selected municipalities in the state 
of Pará, in the Brazilian Amazon Region.
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p = 0.646). However, when we compared the MB and the 
PB patients diagnosed at the leprosy reference unit, sig-
nificant differences were found in both the levels of anti-
PGL-I (p = 0.007) and the proportions of seropositivity 
(MB = 95%, PB = 70%; p = 0.045). Figs 3, 4 illustrate the 
levels of anti-PGL-I in the different groups and Table IV 
shows the median OD values from the ELISA.
Regarding the degree of physical disability, there 
were no differences in the anti-PGL-I levels between 
those with grade 0 (median OD = 0.376; IQR = 0.410) 
and those with grade 1 or 2 (median OD = 0.301; IQR = 
0.778) (p = 0.941). In addition, we did not find a signifi-
cant association (p = 0.709) between the prevalence of 
seropositivity and BCG vaccination status (presence or 
absence of a BCG scar).
Amongst the study participants, 42.5% of the male 
students and 53.3% of the female students were serop-
ositive (p < 0.0001). The median OD for the males was 
0.256 (IQR = 0.262) and the median OD for the females 
was 0.323 (IQR = 0.354) (p < 0.0001), but the number of 
leprosy cases did not differ by gender (p = 0.792).
Thirty-four of the visited schools were in urban zones 
and three schools were in rural zones; we examined 1,428 
urban students (54 new cases) and 164 rural students (9 
new cases). There was no significant difference between 
the proportions of new cases detected in the two areas (p 
= 0.288). The level of anti-PGL-I was higher in the urban 
area (median OD = 0.301; IQR = 0.323) than in the rural 
area (median OD = 0.220; IQR = 0.276) (p < 0.0001) and 
the prevalence of seropositivity was also higher in urban 
areas (urban = 50.7%; rural = 32.3%; p < 0.0001).
Twenty newly diagnosed leprosy cases (23%) re-
ported that they had experienced starvation (a full day 
without meals) at least once because they lacked the re-
sources to buy food, 77 (89%) had family incomes of up 
to twice the Brazilian minimum wage, 73 (84%) were re-
ceiving some type of governmental financial assistance, 
such as a family allowance or retirement benefits, and 
59 (68%) lived in a house with more than two people per 
bedroom. Additionally, 54.5% of the newly diagnosed 
students stated that they were aware of previous contact 
with at least one person affected by leprosy.
TABLE II
Seroprevalence and new cases detected in each municipality
Municipality
Public schoolsa
(enrolled students)
n (%)
Selected schools 
(examined students)
n (%)
Seroprevalence 
among students 
n (%)
New cases  
detected  
among students 
n (%)
HCSDL
survey
(n)
Seroprevalence 
among HCSDL
n (%)
New cases  
detected  
among HCSDL
n (%)
Altamira 115 (24.137) 6 (282) 81 (28.7) 10 (3.5) 30 9 (30) 1 (3.3)
Breves 325 (30.290) 5 (229) 150 (65.5) 14 (6.1) 81 30 (37) 12 (14.8)
Castanhal 82 (39.331) 4 (188) 125 (66.5) 9 (4.8) 31 9 (29) 3 (9.7)
Marituba 57 (24.978) 4 (199) 128 (64.3) 10 (5) 34 19 (55.9) 3 (8.8)
Oriximiná 89 (16.785) 6 (135) 57 (42.2) 6 (4.4) 25 14 (56) 2 (8)
Paragominas 93 (24.182) 4 (181) 84 (46.4) 10 (5.5) 44 22 (50) 3 (6.8)
Parauapebas 50 (33.300) 5 (146) 58 (39.7) 3 (2) 8 3 (37.5) 0 (0)
Redenção 37 (17.581) 3 (232) 94 (40.5) 1 (0.4) 3 1 (33.3) 0 (0)
Total 848 (210.584) 37 (1.592) 777 (48.8) 63 (4) 256 107 (41.8) 24 (9.4)
a: elementary and high schools (Brazilian Institute for Geography and Statistics - ibge.gov.br/estadosat/); HCSDL: household 
contact of student diagnosed with leprosy.
TABLE III
Epidemiologic characteristics of the new cases detected
Category
Students 
survey
HCSDL 
survey Total
n(%) n (%) n(%)
Gender
   Male 26 (41.3) 21 (50) 38 (43.7)
   Female 37 (58.7) 12 (50) 49 (56.3)
Age group
   < 15 years old 42 (66.7) 9 (37.5) 51 (58.6)
   ≥ 15 years old 21 (33.3) 15 (62.5) 36 (41.4)
Classification 
   Paucibacillary 45 (71.4) 9 (37.5) 54 (62.1)
   Multibacillary 18 (28.6) 15 (62.5) 33 (37.9)
Degree of disability
   0 59 (93.6) 20 (83.4) 79 (90.8)
   1 4 (6.4) 2 (8.3) 6 (6.9)
   2 0 (0) 2 (8.3) 2 (2.3)
ELISA anti-PGL-I
   Seropositive 45 (71.4) 11 (45.8) 56 (64.4)
   Seronegative 18 (28.6) 13 (54.2) 31 (35.6)
BCG scar
   None 7 (11.1) 3 (12.5) 10 (11.5)
   One 47 (74.6) 21 (87.5) 68 (78.2)
   Two 6 (9.5) 0 (0) 6 (6.9)
   Dubious 3 (7.8) 0 (0) 3 (3.4)
HCSDL: household contact of student diagnosed with leprosy; 
PGL-I: phenolic glycolipid-I.
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diSCuSSion
From 1991-2010, 88,805 new leprosy cases were di-
agnosed in PA alone (The National Notifiable Diseases 
2012 - portal.saude.gov.br/portal/saude/profissional/vis-
ualizar_texto.cfm?idtxt=31200). Considering that there 
were approximately two million students enrolled in 
public schools in 2009 (Brazilian Institute for Geogra-
phy and Statistics - ibge.gov.br/estadosat/), we examined 
only 0.08% of all the students. If the data we collected 
were extrapolated to the entire population of SC, there 
may currently be approximately 80,000 undiagnosed 
leprosy cases amongst PA students. According to the 
World Health Organization, the peak age range for the 
onset of leprosy is 20-30 years (WHO 2009). However, 
while the diagnosis may occur during this period of life, 
the onset may occur earlier and the patient may be sick 
for a long time. In PA, almost half of the patients have 
been diagnosed between the ages of 20-60 years and in 
the last 20 years, an average of 4,400 patients were diag-
nosed each year. If we assume that the 80,000 currently 
undiagnosed leprosy cases will be detected in the next 
20 years, we may maintain this average for a long time.
In fact, these data may be corroborated by the high 
proportions of anti-PGL-I-positive SC, from 28.7-66.5%. 
These figures are similar to the prevalence of subclini-
cal infection detected by Dayal and Bharadwaj (1995) 
amongst healthy children who were close contacts of 
PB and MB LPs (61% and 75%, respectively). Although 
these numbers are high compared with those of other 
studies involving the general population, there is little 
surveillance of leprosy amongst SC. Some studies re-
port lower seroprevalence rates, even in highly endemic 
regions (Cartel et al. 1990, Bührer-Sékula et al. 2008), 
whereas other studies report high seroprevalence rates 
that are compatible with the high incidence rate of the 
surveyed population (Abe et al. 1990, Van Beers et al. 
1999) and corroborate our results. 
The other interesting findings, already presented in 
other studies (Fine et al. 1988, Krishnamurthy et al. 1991, 
Bakker et al. 2004), are the higher levels of anti-PGL-I 
seropositivity amongst children and young adults com-
pared with older adults (i.e., an inverse correlation with 
age) and amongst girls compared with boys. There is no 
definite explanation for these results, but generally, IgM 
antibody levels vary with age and they are consistently 
higher in females than in males at every age (Oskam et 
al. 2003). Moreover, the difference in seropositivity be-
tween the urban and rural SC may be due to the poorer 
living conditions in urban areas, where the students live 
in more crowded houses and neighbourhoods and are 
more susceptible to food shortages. These observations, 
along with the high seropositivity rate amongst students 
in public schools, led us to question whether higher in-
come students would have the same results. As expect-
ed, the prevalence of anti-PGL-I seropositivity amongst 
SC in private schools was significantly lower than the 
prevalence in public schools, confirming the strong cor-
relation between leprosy and poverty.
Although the seroprevalence rate is high, we must 
remember that M. leprae is a highly infective, but low 
pathogenic bacterium that causes disease in only 10-20% 
of all infected people, considering a positive lepromin test 
in approximately 80% of the population protected by the 
“N-factor of Rotberg” (Rotberg 1989). According to our 
data, almost half of the SC in public schools have sub-
clinical infections and respond by producing anti-PGL-I, 
which can be used as a marker of M. leprae dissemina-
tion into the community (Baumgart et al. 1993). Of the 
two million students enrolled in PA public schools, ap-
proximately one million may be positive for anti-PGL-I. 
A total of 15% of the healthy students in our sample had 
an anti-PGL-I titration that was two times higher than 
our threshold for positivity. If 5% of one million students 
become ill in the coming years, we will have an addition-
al 50,000 new patients in the future, joining the 80,000 
individuals who are currently ill. Some of these patients 
will experience mild signs and symptoms (e.g., single-
lesion PB leprosy) and they may never become registered 
cases if their leprosy heals spontaneously, as described in 
the literature (Jesudasan & Christian 1985).
In fact, when examining the same population months 
after an initial screening for anti-PGL-I, as we did in 
the county of Oriximiná, in the western region of PA 
(Salgado et al. 2012), we found a high number of new 
leprosy cases amongst families with anti-PGL-I-positive 
individuals who were previously undiagnosed. Many 
factors may contribute to this high hidden prevalence. 
The clearest indicator is the low rate of contact examina-
tion, approximately 40% in PA, which is considered to 
be precarious by the Brazilian Ministry of Health (MS/
SVS 2009). Additionally, the low coverage of the popu-
lation by the family health programme, with almost 60% 
of people lacking access to the system (Department of 
Health Care/Department of Primary Care 2012 - dab.
Fig. 3: levels of anti-phenolic glycolipid-I IgM from different groups: 
A: healthy students (n = 1529); B: students diagnosed with leprosy (n 
= 63); C: healthy household contacts (HCCs) of students with leprosy 
(n = 232); D: HCCs of students with leprosy that were also diagnosed 
with leprosy (n = 24); E: endemic controls (ECs) (n = 14); F: non-ECs 
(n = 3); G: paucibacillary patients from the leprosy reference unit 
(RU) (n = 10); H: multibacillary patients from the leprosy RU (n = 
41); OD: optical density.
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saude.gov.br/historico_cobertura_sf.php), may explain 
the high number of undiagnosed leprosy cases. Fur-
thermore, the majority of the cases we diagnosed were 
PB and many of them had only one lesion, sometimes a 
slightly hypochromic macule that was not recognised by 
the patient or family as a lesion. The family health pro-
gramme team may be trained to detect well-established 
leprosy cases with clear symptoms, but the team may not 
be trained to diagnose cases in the early stages, such as 
those that we detected in this study.
Fig. 4A: levels of anti-phenolic glycolipid-I (PGL-I) IgM according to the students gender; B: region of the schools; C: category (public or pri-
vate); D: there was no significant difference according to the degree of physical disability; E: differences between cases detected during school 
survey [paucibacillary (PB) and multibacillary (MB)] and cases referenced to the reference unit (RU); F: correlation between the level of anti-
PGL-I and the age of the household contacts of student diagnosed with leprosy; OD: optical density; UREMC: Dr Marcello Candia Reference 
Unit in Sanitary Dermatology.
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Interestingly, the seropositivity rates amongst the PB 
and MB patients in our sample were almost the same. 
By contrast, the PB patients diagnosed at UREMC had 
a slight, but not significant increase in anti-PGL-I lev-
els, while the UREMC MB patients had a significant 
increase in the median level of anti-PGL-I. These results 
confirm the early diagnosis because we detected more 
PB cases than MB cases and because the MB cases were 
mostly BT patients.
Surveys to detect leprosy among SC are not new. In 
1947, researchers in British Guiana examined 42,811 stu-
dents and found 94 (0.21%) new cases. The author pro-
posed that surveying schools “should become a permanent 
part of the leprosy public health program” and concluded 
that without the study, the early cases might not have been 
identified until they were more advanced and difficult 
to cure (Wharton 1947). In a study similar to ours that 
was performed in India, Bhavasr and Mehta (1981) dem-
onstrated that school surveys and contact examination of 
children could be considered to be a useful, inexpensive 
and rapid method for detecting leprosy cases in the com-
munity. In that study, visits to the homes of 24 new stu-
dent cases revealed a family history of leprosy for 50% of 
the affected students. Similarly, Thirumalaikolundusub-
ramanian and Prince (1983) examined 6,731 primary SC 
in India and 173 (2.7%) had leprosy. Silva et al. (2007) 
detected 20 new leprosy cases during an active search 
of 14,653 students, a case detection rate of 136/100,000 
students, in Buriticupu, a hyperendemic municipality in 
the state of Maranhão (Brazil). In a cross-sectional sur-
vey of 1,114 students 11-20 years old in four districts in 
Timor-Lest, dos Santos et al. (2010) detected 17 (1.5%) 
new leprosy cases, which represents a case detection rate 
of 1,526/100,000 students. All five of these studies cor-
roborate our findings. In addition to a high number of new 
student cases (63 cases out of 1,592 examined; 4%), we 
found 24 (9.4%) new cases amongst 256 HHCs of the stu-
dents diagnosed with leprosy. This result clearly indicates 
that the contacts of infected students must be examined in 
addition to the students themselves.
Previously, we performed a study in the county of 
Oriximiná based on our serological data and found 
a high number of hidden cases (Salgado et al. 2012). 
Similarly, we performed a more thorough study in the 
county of Castanhal, where SC and family members of 
anti-PGL-I-positive individuals (identified 2 years ago) 
were examined. We identified more than 60 new cases of 
leprosy among approximately 400 examined individu-
als (unpublished observations), thus demonstrating the 
effectiveness of our strategy. In addition, we provided 
an in-service training session for the municipality health 
team workers.
Our results suggest that implementing school sur-
veys for identifying leprosy cases is imperative in highly 
endemic areas. The advantage of our strategy is that it 
identifies early cases of leprosy (mainly PB cases) with 
no physical disabilities, thus preventing the spread of the 
infection in the community and breaking the chain of 
transmission that is responsible for the high incidence 
rate observed over time. 
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